Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

2 ArticlesMylan

1 / 1

Strides Gets a $30m Escrow Payout After Settling with Mylan for $70m for Regulatory Issues

In the latest filing with the exchange, Strides Shasun has settled with Mylan for about $70 million for Regulatory and General Claims on the $1.75 ...

Nov 03, 2016

Strides-Share-Price-3-November-2016.png

EMA agrees to review Mylan and Biocon’s Regulatory Submission for proposed biosimilar Pegfilgrastim

European Medical Agency has accepted the submission for the review of the biosimilar Pegfilgrastim co-developed by Mylan & Biocon. The proposed ...

Jul 21, 2016

Biocon-Share-Price-July-2016.png

Join Capitalmind Premium

Starts at ₹1,999/mo

Get access to our equity, fixed income, macro and personal finance research, model equity and fixed-income portfolios, exclusive apps, tutorials, and member community.